| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |